Medicine and Dentistry
Cohort Analysis
100%
Meta-Analysis
89%
Systematic Review
89%
Prevalence
61%
Endocrinology
42%
Breast Cancer
40%
Hazard Ratio
38%
Hypothyroidism
30%
Clinical Guideline
24%
Clinical Endocrinology
23%
Pituitary Tumour
23%
Cherubism
23%
Acromegaly
23%
Endocrine Disease
22%
Observational Study
20%
Adrenal Insufficiency
19%
Maturity Onset Diabetes of the Young
18%
Cardiovascular System
18%
Cancer Risk
18%
Hydrocortisone
18%
Infection
17%
All Cause Mortality
17%
Cushing Syndrome
17%
Albright's Hereditary Osteodystrophy
16%
Hyperthyroidism
16%
Cancer
16%
COVID-19
15%
Glucocorticoid
15%
Malignant Neoplasm
15%
Hydrocortisone Release
14%
Hypercortisolism
13%
Clinician
11%
Adrenal Incidentaloma
11%
Venous Thromboembolism
11%
Quality of Life
11%
Body Mass Index
11%
Health Care
10%
Atrial Fibrillation
10%
Standardized Incidence Ratio
9%
Carcinoma
9%
Cohort Effect
9%
Clinical Trial
9%
Patient with Type 2 Diabetes
9%
Prognostic Factor
9%
Symptom
9%
Heart Failure
9%
Proportional Hazards Model
8%
Pituitary Adenoma
8%
Subclinical Hypothyroidism
8%
Population
8%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
78%
Adrenal Insufficiency
32%
Glucocorticoid
32%
Breast Cancer
31%
Hypothyroidism
23%
Acromegaly
23%
Venous Thromboembolism
22%
Malignant Neoplasm
18%
Prevalence
16%
Non Insulin Dependent Diabetes Mellitus
15%
Infection
15%
Standardized Incidence Ratio
14%
Disease
14%
Comorbidity
14%
Symptom
11%
Observational Study
10%
All Cause Mortality
9%
Diabetes Mellitus
9%
Recurrent Disease
9%
Endocrine Disease
9%
Replacement Therapy
8%
Hydrocortisone
8%
Statin (Protein)
8%
Multiple Endocrine Neoplasia Type 1
7%
Antithrombotic Therapy
7%
Nerve Growth Factor
7%
Growth Hormone
7%
Atrial Fibrillation
7%
Coronavirinae
7%
Hypoparathyroidism
7%
Case-Control Study
7%
Bleeding
7%
Migraine
7%
Subclinical Hypothyroidism
7%
Diverticulitis
7%
Thyroid Hormone
7%
Diverticulosis
7%
Hemoglobin A
7%
Glutamic Acid
7%
Hyperprolactinemia
7%
Calcitonin Gene Related Peptide
7%
Diabetic Neuropathy
7%
Multiple Myeloma
7%
Antianemic Agent
7%
Acute Kidney Failure
7%
Brain Hemorrhage
7%
Hyperthyroidism
7%
Myelodysplastic Syndrome
7%
Vein Superficial Thrombosis
7%
Endocrine Therapy
7%